These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17982927)

  • 1. Effects on nasal nitric oxide production of 2 mechanisms of vasoconstriction.
    Serrano C; Valero A; Bartra J; Torrego T; Mullol J; Picado C
    J Investig Allergol Clin Immunol; 2007; 17(5):337-40. PubMed ID: 17982927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of topical xylometazoline on the mucosal temperature of the nasal septum.
    Lindemann J; Leiacker R; Rettinger G; Keck T
    Am J Rhinol; 2002; 16(4):229-34. PubMed ID: 12222949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal and bronchial response to exercise in patients with asthma and rhinitis: the role of nitric oxide.
    Valero A; Serrano C; Valera JL; Barberá A; Torrego A; Mullol J; Picado C
    Allergy; 2005 Sep; 60(9):1126-31. PubMed ID: 16076296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia depresses nitric oxide output in the human nasal airways.
    Haight JS; Qian W; Daya H; Chalmers P; Zamel N
    Laryngoscope; 2000 Mar; 110(3 Pt 1):429-33. PubMed ID: 10718433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling.
    Graf P; Juto JE
    Rhinology; 1995 Mar; 33(1):14-7. PubMed ID: 7540314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate effect of benzalkonium chloride in decongestant nasal spray on the human nasal mucosal temperature.
    Lindemann J; Leiacker R; Wiesmiller K; Rettinger G; Keck T
    Clin Otolaryngol Allied Sci; 2004 Aug; 29(4):357-61. PubMed ID: 15270822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal nitric oxide is increased in allergic rhinitis.
    Arnal JF; Didier A; Rami J; M'Rini C; Charlet JP; Serrano E; Besombes JP
    Clin Exp Allergy; 1997 Apr; 27(4):358-62. PubMed ID: 9146927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Improving wound healing after nose surgery by combined administration of xylometazoline and dexpanthenol].
    Kehrl W; Sonnemann U
    Laryngorhinootologie; 2000 Mar; 79(3):151-4. PubMed ID: 10763172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of topical steroid on oral and nasal nitric oxide production in patients with allergic rhinitis].
    Gao Q; Zhang Y; Wang C; Zhao Y; Zhang L
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Oct; 25(20):913-5, 919. PubMed ID: 22239049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decongestant activity of a new formulation of xylometazoline nasal spray: a double-blind, randomized versus placebo and reference drugs controlled, dose-effect study.
    Castellano F; Mautone G
    Drugs Exp Clin Res; 2002; 28(1):27-35. PubMed ID: 12073765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Temperature and humidity profile of the paranasal sinuses before and after mucosal decongestion by xylometazolin].
    Keck T; Leiacker R; Schick M; Rettinger G; Kühnemann S
    Laryngorhinootologie; 2000 Dec; 79(12):749-52. PubMed ID: 11199458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of topical tuaminoheptane combined with N-acetyl-cysteine in reducing nasal resistance. A double-blind rhinomanometric study versus xylometazoline and placebo.
    Cogo A; Chieffo A; Farinatti M; Ciaccia A
    Arzneimittelforschung; 1996 Apr; 46(4):385-8. PubMed ID: 8740084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensory neuropeptides and nitric oxide in nasal vascular regulation.
    Rinder J
    Acta Physiol Scand Suppl; 1996; 632():1-45. PubMed ID: 8800374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somato-sympathetic vasoconstriction to intranasal fluid administration with consecutive decrease in nasal nitric oxide.
    Landis BN; Beghetti M; Morel DR; Giger R; Rimensberger PC; Lacroix JS
    Acta Physiol Scand; 2003 Apr; 177(4):507-15. PubMed ID: 12648168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of nitric oxide synthase by nasal decongestants.
    Westerveld GJ; Voss HP; van der Hee RM; de Haan-Koelewijn GJ; den Hartog GJ; Scheeren RA; Bast A
    Eur Respir J; 2000 Sep; 16(3):437-44. PubMed ID: 11028657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold.
    Eccles R; Martensson K; Chen SC
    Curr Med Res Opin; 2010 Apr; 26(4):889-99. PubMed ID: 20151787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepant nasal and bronchial nitric oxide kinetics during early and late phase allergic reactions.
    Korn S; Beier J; Heilmann C; Kornmann O; Buhl R; Michael Beeh K
    Respir Med; 2005 Dec; 99(12):1595-9. PubMed ID: 16291080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nasal decongestant effect of xylometazoline in the common cold.
    Eccles R; Eriksson M; Garreffa S; Chen SC
    Am J Rhinol; 2008; 22(5):491-6. PubMed ID: 18655753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of nasal cycle by acoustic rhinometry and rhinomanometry.
    Huang ZL; Ong KL; Goh SY; Liew HL; Yeoh KH; Wang DY
    Otolaryngol Head Neck Surg; 2003 Apr; 128(4):510-6. PubMed ID: 12707653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal nitric oxide is independent of nasal cavity volume.
    Chatkin JM; Djupesland PG; Qian W; McClean P; Furlott H; Gutierrez C; Zamel N; Haight JS
    Am J Rhinol; 1999; 13(3):179-84. PubMed ID: 10392235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.